Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Keytruda "not very good and costly..."

<< Previous

Bullboard Posts

Next >>

Comment by jmm1228on Apr 13, 2023 11:50am

142 Views

Post# 35393144

RE:RE:Keytruda "not very good and costly..."

If I was a Merck Board member I'd be puouding the table about acquiring TLT.

If I was a Board Member of any other Big Pharma I'd be pounding the table about making certain Merck doesn't get it's paws on TLT.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing